Jasmeer Chhatwal
Overview
Explore the profile of Jasmeer Chhatwal including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
51
Citations
2955
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Bateman R, Li Y, McDade E, Llibre-Guerra J, Clifford D, Atri A, et al.
medRxiv
. 2025 Feb;
PMID: 39974075
Background: Amyloid-plaque removal by monoclonal antibody therapies slows clinical progression in symptomatic Alzheimer's disease; however, the potential for delaying the onset of clinical symptoms in asymptomatic people is unknown. The...
2.
Birkenbihl C, Cuppels M, Boyle R, Klinger H, Langford O, Coughlan G, et al.
Brain Inform
. 2025 Jan;
12(1):3.
PMID: 39871006
Cognitive resilience (CR) describes the phenomenon of individuals evading cognitive decline despite prominent Alzheimer's disease neuropathology. Operationalization and measurement of this latent construct is non-trivial as it cannot be directly...
3.
Sewell K, Doecke J, Xiong C, Benzinger T, Masters C, Laske C, et al.
Alzheimers Dement
. 2024 Sep;
20(11):7923-7939.
PMID: 39324510
Introduction: We investigated longitudinal associations between self-reported exercise and Alzheimer's disease (AD)-related biomarkers in individuals with autosomal dominant AD (ADAD) mutations. Methods: Participants were 308 ADAD mutation carriers aged 39.7 ...
4.
Birkenbihl C, Cuppels M, Boyle R, Klinger H, Langford O, Coughlan G, et al.
medRxiv
. 2024 Sep;
PMID: 39228697
Cognitive resilience describes the phenomenon of individuals evading cognitive decline despite prominent Alzheimer's disease neuropathology. Operationalization and measurement of this latent construct is non-trivial as it cannot be directly observed....
5.
McDade E, Liu H, Bui Q, Hassenstab J, Gordon B, Benzinger T, et al.
Res Sq
. 2024 Aug;
PMID: 39108475
This study explored the role of the ubiquitin-proteasome system (UPS) in dominantly inherited Alzheimer's disease (DIAD) by examining changes in cerebrospinal fluid (CSF) levels of UPS proteins along with disease...
6.
Iaccarino L, Llibre-Guerra J, McDade E, Edwards L, Gordon B, Benzinger T, et al.
Brain Commun
. 2024 May;
6(3):fcae159.
PMID: 38784820
Approximately 5% of Alzheimer's disease patients develop symptoms before age 65 (early-onset Alzheimer's disease), with either sporadic (sporadic early-onset Alzheimer's disease) or dominantly inherited (dominantly inherited Alzheimer's disease) presentations. Both...
7.
8.
Wagemann O, Liu H, Wang G, Shi X, Bittner T, Scelsi M, et al.
JAMA Neurol
. 2024 Apr;
81(6):582-593.
PMID: 38683602
Importance: Effects of antiamyloid agents, targeting either fibrillar or soluble monomeric amyloid peptides, on downstream biomarkers in cerebrospinal fluid (CSF) and plasma are largely unknown in dominantly inherited Alzheimer disease...
9.
Llibre-Guerra J, Iaccarino L, Coble D, Edwards L, Li Y, McDade E, et al.
Brain Commun
. 2023 Nov;
5(6):fcad280.
PMID: 37942088
Approximately 5% of Alzheimer's disease cases have an early age at onset (<65 years), with 5-10% of these cases attributed to dominantly inherited mutations and the remainder considered as sporadic....
10.
Xu Y, Aung H, Bateman R, Brooks W, Chhatwal J, Day G, et al.
Alzheimers Dement
. 2023 Apr;
19(11):4999-5009.
PMID: 37087693
Background: The Dominantly Inherited Alzheimer Network (DIAN) is a longitudinal observational study that collects data on cognition, blood pressure (BP), and other variables from autosomal-dominant Alzheimer's disease mutation carriers (MCs)...